- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 28,340,478
- Share change
- -360,824
- Total reported value
- $599,385,890
- Put/Call ratio
- 231%
- Price per share
- $21.15
- Number of holders
- 140
- Value change
- -$18,947,335
- Number of buys
- 58
- Number of sells
- 74
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
|
Company |
1.6%
|
4,118,085
|
$115,512,000 | — | 31 Mar 2021 | |
| Bellevue Group AG |
13F
|
Company |
1.5%
|
3,989,164
|
$111,896,000 | — | 31 Mar 2021 | |
| Meditor Group Ltd |
13F
|
Company |
1%
|
2,679,835
|
$75,169,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.9%
|
2,319,113
|
$65,051,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.83%
|
2,146,396
|
$60,208,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.82%
|
2,118,446
|
$59,422,000 | — | 31 Mar 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.62%
|
1,600,613
|
$44,897,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.4%
|
1,029,701
|
$28,882,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.25%
|
648,200
|
$18,182,000 | — | 31 Mar 2021 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.24%
|
607,580
|
$17,043,000 | — | 31 Mar 2021 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.23%
|
592,225
|
$16,612,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.19%
|
500,000
|
$14,025,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
448,663
|
$12,584,000 | — | 31 Mar 2021 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.14%
|
373,500
|
$10,477,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
322,614
|
$9,049,000 | — | 31 Mar 2021 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.12%
|
315,920
|
$8,862,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
304,925
|
$8,554,000 | — | 31 Mar 2021 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.1%
|
267,011
|
$7,490,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
0.09%
|
227,943
|
$6,394,000 | — | 31 Mar 2021 | |
| Swedbank AB |
13F
|
Company |
0.08%
|
217,000
|
$6,086,850 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
214,134
|
$6,007,000 | — | 31 Mar 2021 | |
| BIOTECH TARGET N V |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,477,964
|
$5,575,065 | — | 24 May 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
186,182
|
$5,223,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
177,316
|
$4,974,000 | — | 31 Mar 2021 | |
| Cinctive Capital Management LP |
13F
|
Company |
0.07%
|
172,463
|
$4,838,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
165,031
|
$4,629,000 | — | 31 Mar 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.05%
|
129,389
|
$3,629,000 | — | 31 Mar 2021 | |
| AXA S.A. |
13F
|
Company |
0.05%
|
127,146
|
$3,566,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.05%
|
124,787
|
$3,501,000 | — | 31 Mar 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.04%
|
116,133
|
$3,259,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.04%
|
109,815
|
$3,080,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
107,702
|
$3,020,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
101,292
|
$2,841,000 | — | 31 Mar 2021 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
76,831
|
$2,155,000 | — | 31 Mar 2021 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.03%
|
71,527
|
$2,004,000 | — | 31 Mar 2021 | |
| GAM Holding AG |
13F
|
Company |
0.03%
|
70,700
|
$1,983,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
66,575
|
$1,867,000 | — | 31 Mar 2021 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.02%
|
64,434
|
$1,807,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
60,500
|
$1,697,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
60,271
|
$1,691,000 | — | 31 Mar 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
57,343
|
$1,608,000 | — | 31 Mar 2021 | |
| Endurant Capital Management LP |
13F
|
Company |
0.02%
|
55,540
|
$1,558,000 | — | 31 Mar 2021 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.02%
|
55,338
|
$1,552,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
53,514
|
$1,501,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
52,800
|
$1,481,000 | — | 31 Mar 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.02%
|
50,429
|
$1,415,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
48,670
|
$1,365,000 | — | 31 Mar 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
41,129
|
$1,154,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
39,357
|
$1,104,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
39,039
|
$1,095,000 | — | 31 Mar 2021 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q2 2021
As of 30 Jun 2021,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,340,478 shares.
The largest 10 holders included
Bellevue Group AG, WASATCH ADVISORS INC, Meditor Group Ltd, VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., PLATINUM INVESTMENT MANAGEMENT LTD, MARSHALL WACE, LLP, Rhenman & Partners Asset Management AB, and BOXER CAPITAL, LLC.
This page lists
140
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
151
Q2 2021 holders
140
Holder diff
-11
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.